Quest Diagnostics Profile

USD 0.12  0.12%

Sale by Jenne Britell of 6111 shares of Quest Diagnostics

Quest Diagnostics Incorporated insider trading alert for sale of common stock by Jenne Britell, the corporate stakeholder, on October 17, 2018. This event was filed by Quest Diagnostics Inc with SEC on 2017-04-26. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Quest Diagnostics Summary

Quest Diagnostics Incorporated (DGX) is traded on BATS Exchange in USA. It is located in New Jersey U.S.A and employs 45,000 people. Quest Diagnostics is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 14.12 B. Quest Diagnostics Incorporated runs under Healthcare sector within Diagnostics & Research industry. This company has 136.67 M outstanding shares of which 2.39 M shares are currently shorted by investors with about 3.12 days to cover shorted positions. QUEST DIAGNOSTC has about 132 M in cash with 718.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97.
Check Quest Diagnostics Probability Of Bankruptcy

Ownership Allocation (%)

Quest Diagnostics Target Price Odds Analysis

Odds Below 102.38HorizonTargetOdds Above 102.38
58.85%30 days 102.38 41.07%
Based on normal probability distribution, the odds of Quest Diagnostics to move above current price in 30 days from now is about 41.07% (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Diagnostics Stock to fall within a particular range of prices over 30 days) .

Quest Diagnostics Top Holders

Quest Diagnostics Incorporated Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Quest Diagnostics Key Fundamentals

Quest Diagnostics Against Markets

Quest Diagnostics Current Ratings

Quest Diagnostics Incorporated 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Quest Diagnostics Incorporated are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 45000 people. more
Fama & French Healthcare
Fama & French Classification
Quest Diagnostics SEC Filings
Quest Diagnostics SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameQuest Diagnostics Incorporated
CEOStephen RusckowskiView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
RegionNorth America
LocationNew Jersey U.S.A
Business Address500 Plaza Drive
ExchangeBATS Exchange
CIK Number0001022079
IndustryDiagnostics & Research
Phone973 520 2700
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestSeptember 14, 2018

Current Sentiment - DGX

Quest Diagnostics Investor Sentiment

Greater number of Macroaxis users are currently bullish on Quest Diagnostics Incorporated. What is your perspective on investing in Quest Diagnostics Incorporated? Are you bullish or bearish?
98% Bullish
2% Bearish

Quest Diagnostics Dividends

Upcoming distributions to stockholders

Quest Diagnostics Directors

Quest Diagnostics Corporate Directors

Gail Wilensky Independent Director
Jenne Britell Independent Director
Shawn Bevec Executive Director Investor Relations
Additionally see Investing Opportunities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.